CUMS IMC/GAP certified smokable dry flower / flos, and GACP Biomass at scale
We have more than 2560+ varieties available for cultivation on demand. From these varieties, we have curated close to 50 different strains with specific characteristics that make them more suitable for treating particular pathologies.
The identification of patterns in the expression of cannabinoids and terpenes in relation to their total concentration, allows us to better recommend our varieties to help in the treatment of specific pathologies.
Smart dry flower
Our goal is to select from a large number of commercially available strains a particular set of chemotypes, focusing on the expression of their active components.
Remidi #1
Main Cannabinoids: CBD: 14.5% ±2.5 % THC: ≤0.9%
Description: Genetics expressed in a tall and elongated architecture. Remedy #1 outstands for its high CBD content and large number of floral buds.
Recommended therapeutic application:
Remidi #2
Main Cannabinoids: CBD: 13.8% ±1.8; THC: ≤0.9%
Description: High yields in size and flower weight. Production of large compact flowers, especially in the apical flower.
Recommended therapeutic application:
Remidi #3
Main Cannabinoids: THC: 21% ±0.9; CBD: ≤0.1%
Description: Compact flower, rosemary and thyme aroma & strong wooden scent.
Recommended therapeutic application:
Remidi #4
Main Cannabinoids: THC: 23.7% ±1.9; CBD: ≤0.05%
Description: Compact buds with very dominant pine tree aroma, plus citrus notes. This strain is characterized by its high THC content.
Recommended therapeutic application:
Remidi #5
Main Cannabinoids: THC: 21.8% ±0.9 CBD: ≤0.05%
Description: Open and dense buds, still very resinous with strong citrus aroma.
Recommended therapeutic application:
